Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Castration remains despite decreasing definitive treatment of localized prostate cancer in the elderly: A case for de-implementation.
The enzymology of proinsulin conversion.
Feasibility and Realization of Single-Pulse Laue Diffraction on Macromolecular Crystals at ESRF.
Modern Management of Perianal Crohn's Disease: A Review.
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor.
See All 19 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor.
LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor. Cell Metab. 2018 02 06; 27(2):461-469.e6.
View in:
PubMed
subject areas
Animals
Bariatric Surgery
Caloric Restriction
Eating
Fasting
Female
Ghrelin
Growth Hormone
Hepcidins
Humans
Intestine, Small
Liver
Male
Mice
Protein Binding
Rats
Receptors, Ghrelin
authors with profiles
Olivier G. Dalmas